Rituximab antibody (FITC)

Details for Product No. ABIN2476370
Antigen
Reactivity
Chemical
15
Host
Rat
8
6
2
Clonality (Clone)
Monoclonal ()
Conjugate
FITC
4
3
Application
Flow Cytometry (FACS)
11
6
2
2
Options
Clone MB2A4
Isotype IgG2a
Characteristics Purified IgG
Antigen
Target Type Chemical
Background Synonyms: MabThera ® , Rituxan®
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Concentration 0.1 mg/mL
Product cited in: Cragg, Bayne, Illidge, Valerius, Johnson, Glennie: "Apparent modulation of CD20 by rituximab: an alternative explanation." in: Blood, Vol. 103, Issue 10, pp. 3989-90; author reply 3990-1, 2004 (PubMed).

Cragg, Bayne, Tutt, French, Beers, Glennie, Illidge: "A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells." in: Blood, Vol. 104, Issue 8, pp. 2540-2, 2004 (PubMed).

Beum, Kennedy, Li, Pawluczkowycz, Williams, Taylor: "Complement activation and C3b deposition on rituximab-opsonized cells substantially blocks binding of phycoerythrin-labeled anti-mouse IgG probes to rituximab." in: Journal of immunological methods, Vol. 294, Issue 1-2, pp. 37-42, 2004 (PubMed).

Did you look for something else?